Lu is a PhD candidate in the college of Medicine, National Taiwan University. He is a leader of the project which focuses on overcoming Osimertinib resistance in NSCLC treatment. The research interest is oncology especially in lung cancer and small molecule drug development. His team has been working on the development of small molecule drugs for more than 10 years with oncologist, chemist, biologist and MD included.
Speaking In
[Available On-Demand]
SPARK Program was launched in accordance with SPARK Taiwan cultivates future teams and team…